NUCLEUS
Cochlear Limited
Trademark Registered: 2022-06-07
Trademark Application Details
NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
| Research |
OneLook
Acronym Finder
|
| Serial Number | 79308449 |
| Registration Number | 6749230 |
| Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
Timeline
| 2021-02-17 | Application Filed |
| 2021-04-08 | Location: INITIAL REVIEW/SERIALIZATION BRANCH(MAILROOM) |
| 2021-04-08 | Status: Live/Pending |
| 2021-04-09 | Transaction Date |
| 2022-06-07 | Trademark Registered |
Trademark Applicants & Owners
| Owner: |  Cochlear Limited |
| Entity Statement | Australian Public Company, Limited By Shares |
| Address | 1 University Avenue, Macquarie University NSW 2109 AU |
| Legal Entity Type | |
| Legal Entity State | AU |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 5 |
| U.S. Codes: | 005,006,018,044,046,051,052 |
| Type Code | Type |
|---|---|
| GS0051 | Pharmaceutical preparations; medical preparations; pharmaceutical drugs; corticosteroids; dexamethasone; anti-inflammatory drugs; sprays (preparations) for the body (for medical use); medical disinfectants; antiseptics; medicated cleaning preparations for instruments; chemical reagents for medical purposes; chemical preparations for medical purposes |
| GS0051 | Pharmaceutical preparations for the treatment of inflammation or fibrosis, the preservation or improvement of neural structures or functions, or the inhibition of osteoneogenesis; medical preparations for the treatment of inflammation or fibrosis, the preservation or improvement of neural structures or functions, or the inhibition of osteoneogenesis; pharmaceutical drugs for the treatment of inflammation or fibrosis, the preservation or improvement of neural structures or functions, or the inhibition of osteoneogenesis; corticosteroids; dexamethasone; anti-inflammatory, anti-fibrotic, anti-apoptotic, anti-oxidant, immunosuppressing, neuroprotective, neurotrophic and neuroregenerative drugs; pharmaceutical sprays for the body for the treatment of inflammation or fibrosis, the preservation or improvement of neural structures or functions, or the inhibition of osteoneogenesis; medical disinfectants; antiseptics; disinfectant medicated cleaning preparations for instruments; chemical reagents for medical purposes; chemical preparations for medical purposes, namely, for the treatment of inflammation or fibrosis, the preservation or improvement of neural structures or functions, or the inhibition of osteoneogenesis |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| SN ASSIGNED FOR SECT 66A APPL FROM IB | 2021-04-08 | 1 REPR M: |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2021-04-09 | 2 NWOS I:Incoming Correspondence |
| APPLICATION FILING RECEIPT MAILED | 2021-04-13 | 3 MAFR O:Outgoing Correspondence |
| ASSIGNED TO EXAMINER | 2021-06-03 | 4 DOCK D:Assigned to Examiner |
| NON-FINAL ACTION WRITTEN | 2021-06-07 | 5 CNRT R:Renewal |
| NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | 2021-06-08 | 6 RFCR E:E-Mail |
| REFUSAL PROCESSED BY MPU | 2021-06-11 | 7 RFRR P: |
| NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | 2021-06-11 | 8 RFCS P: |
| REFUSAL PROCESSED BY IB | 2021-07-05 | 9 RFNT P: |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2021-12-13 | 10 TROA I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2021-12-13 | 11 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2021-12-14 | 12 TEME I:Incoming Correspondence |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2022-01-07 | 13 CNSA O:Outgoing Correspondence |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2022-01-26 | 14 NONP E:E-Mail |
| NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | 2022-01-26 | 15 OP2R P: |
| NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | 2022-01-26 | 16 OPNS P: |
| NOTIFICATION PROCESSED BY IB | 2022-02-14 | 17 GPNX P: |
| PUBLISHED FOR OPPOSITION | 2022-02-15 | 18 PUBO A:Allowance for Publication |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2022-02-15 | 19 NPUB E:E-Mail |
| ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED | 2022-04-01 | 20 ERRR O:Outgoing Correspondence |
| ELECTRONIC RECORD REVIEW COMPLETE | 2022-04-29 | 21 FIXD O:Outgoing Correspondence |
| REGISTERED-PRINCIPAL REGISTER | 2022-06-07 | 22 R.PR A:Allowance for Publication |
| NOTICE OF REGISTRATION CONFIRMATION EMAILED | 2022-06-07 | 23 NRCC E:E-Mail |
| NEW REPRESENTATIVE AT IB RECEIVED | 2022-08-14 | 24 NREP P: |
| FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | 2022-09-07 | 25 FICR P: |
| FINAL DISPOSITION PROCESSED | 2022-09-19 | 26 FIMP P: |
| FINAL DISPOSITION NOTICE SENT TO IB | 2022-09-20 | 27 FICS P: |
| FINAL DECISION TRANSACTION PROCESSED BY IB | 2022-10-10 | 28 FINO P: |
Similar Marks
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 